Skip to main content

Month: September 2020

BioNTech gibt Pressekonferenz, um Update zu Produktionsplan für COVID-19 Impfstoff bekannt zu geben

Mainz, Deutschland, Sept. 17, 2020 (GLOBE NEWSWIRE) — Mainz, Deutschland, 17. September 2020 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) wird am Donnerstag, den 17. September 2020 um 10.00 MEZ eine Pressekonferenz, einschließlich Videoübertragung abhalten, um ein Update zu dem Produktionsplan für das globale COVID-19-Impfstoffprogramm BNT162 bekannt zu geben. Die Veranstaltung wird ausschließlich in deutscher Sprache stattfinden.Interessierte Journalisten können sich mittels folgendem Link 10-15 Minuten vor Beginn der Konferenz einwählen. Bitte registrieren sie sich hier. Fragen können mittels des Online-Tools gestellt werden.Teilnehmer können außerdem die Pressekonferenz, einschließlich der Videoübertragung auf https://biontech.de/ unter „Events & Presentations“ im Investor & Medien-Bereich der Webseite einsehen. Ein...

Continue reading

Nuvei Corporation Announces Pricing of Initial Public Offering

MONTREAL, Sept. 16, 2020 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) announced today that it has obtained a receipt for its final base PREP prospectus filed with the securities regulatory authorities in each of the provinces and territories of Canada and has entered into an underwriting agreement in respect of its initial public offering consisting of a treasury offering by the Company and a secondary offering by certain funds managed by Novacap Management Inc. (the “Selling Shareholders”) of an aggregate of 26,923,077 subordinate voting shares of the Company at a price of US$26 per share, above the initial marketing range of US$20 to US$22 per share, for aggregate gross proceeds of US$700 million, with the Company and the Selling Shareholders receiving gross proceeds of US$625 million and US$75 million, respectively....

Continue reading

Corporation Nuvei annonce la fixation du prix de son premier appel public à l’épargne

MONTRÉAL, 16 sept. 2020 (GLOBE NEWSWIRE) — Corporation Nuvei  (« Nuvei » ou la « Société ») a annoncé aujourd’hui qu’elle a obtenu un visa pour son prospectus de base – RFPV définitif déposé auprès des autorités en valeurs mobilières de chacune des provinces et de chacun des territoires du Canada et qu’elle a conclu une convention de prise ferme à l’égard de son premier appel public à l’épargne, lequel consiste en un placement d’actions nouvelles par la Société et un placement secondaire par certains fonds gérés par Novacap Management Inc. (les « Actionnaires vendeurs ») d’un total de 26 923 077 actions à droit de vote subordonné de la Société à un prix de 26 $ US par action, soit un prix supérieur à la fourchette de commercialisation initiale de 20 $ US à 22 $ US par action, pour un produit brut total de 700 M$ US, la Société...

Continue reading

Macarthur signs agreement with Canaria Technologies on cutting-edge safety technology

VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the “Company” or “Macarthur”) announces that it has signed an Agreement (“Agreement”) with Canaria Technologies Pty Ltd (“Canaria”) to facilitate the introduction, testing and potential use of Canaria’s Biometrics Safety System at the Company’s flagship Lake Giles Iron Project (“Project”) in the Yilgarn region of Western Australia.Predictive Biometric Systems are a new field of science, combining live and historical data about a user’s body and vital signs with cutting edge Artificial Intelligence to predict future medical or human safety-based incidents.Canaria pairs the data science of predictive biometric systems with medical-grade hardware to create predictive wearable devices, able to measure a user’s...

Continue reading

Macarthur’s Pilbara gold and lithium tenements Earn-in Agreement with Fe Limited, comes to an end

VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the “Company” or “Macarthur”) informs shareholders that Fe Limited (“FEL”) has elected not to earn-in on a 25% Stage 1 Interest (“Stage 1 Interest”) in Macarthur Lithium Pty Ltd’s (“MLi”) gold and lithium tenements in the Pilbara region of Western Australia, pursuant to the Option Agreement executed between the parties in 2019. Following FEL’s decision, the parties have finalised arrangements for the orderly close-out of the joint venture, with effect from 15 September 2020. Macarthur (through MLi) now retains 100% of the Tenements.In 2019, MLi (a wholly owned subsidiary of Macarthur) and FEL entered into an exclusive Option Agreement (“Option Agreement”) for FEL to earn up to a 75% interest in MLi’s...

Continue reading

Lift & Co. Corp. Makes Voluntary Assignment into Bankruptcy Under the Bankruptcy and Insolvency Act (Canada) after Failing to Reach Agreement With Secured Creditors to Proposed Sale of Marketing Division

TORONTO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Lift & Co. Corp. (TSXV:LIFT) (OTCQB:LFCOF) (“Lift & Co.” or the “Corporation”) announced today that it has made a voluntary assignment for the benefit of its creditors under section 49 of the Bankruptcy and Insolvency Act (Canada) and that all of its directors and officers have resigned. This follows the failure to reach an agreement with the holders (the “Debentureholders”) of the Corporation’s secured convertible debentures in the aggregate principal amount of $3,500,000 to the proposed sale of the Corporation’s Consumer Marketing and Trade Marketing Divisions and the “Cohesion” brand (its CannSell, Lift.co and Cohesion lines of business), including all associated goodwill (the “Marketing Division”).Prior to the onset of the COVID-19 pandemic, Lift & Co. had been negotiating...

Continue reading

Forterra Announces Pricing of Secondary Offering of 10,000,000 Shares

IRVING, Texas, Sept. 16, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (the “Company” or “Forterra”) (NASDAQ: FRTA) announced today the pricing of the previously announced underwritten secondary offering by the Company’s largest stockholder, an affiliate of Lone Star Funds (the “Selling Stockholder”), of 10,000,000 shares of common stock of the Company, at a price of $13.50 per share (before underwriting discounts and commissions).  The Selling Stockholder has also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock of the Company at the public offering price.  The Selling Stockholder will receive all of the proceeds from the sale of shares in this offering.  No shares are being sold by the Company.  The offering is expected to close on September 21, 2020.Credit Suisse, BofA Securities...

Continue reading

Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares

DUBLIN, Ireland and TREVOSE, Pa., Sept. 16, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it has priced its previously announced underwritten public offering.  The Company is offering 11,111,111 ordinary shares at a price to the public of $2.25 per share for total gross proceeds of approximately $25.0 million, before deducting the underwriting discount and estimated offering expenses payable by the Company. The offering is expected to close on or about September 21, 2020, subject to the satisfaction of customary closing conditions. In addition, the Company granted the underwriters a 30-day option to purchase up to an additional...

Continue reading

ETC Announces the Final Acceptance by the U.S. Air Force of a Suite of Four Research Altitude Chambers

SOUTHAMPTON, Pa., Sept. 16, 2020 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC”) announces the final acceptance by the U.S. Air Force of a suite of four Research Altitude Chambers delivered to the 711th Human Performance Wing at Wright-Patterson Air Force Base in Dayton, OH, USA. Valued at over $38 million, the suite of research altitude chambers allows maximum flexibility in the configuration of unique test scenarios under a wide range of environmental conditions. Three of the four chambers are “man-rated” allowing human occupancy for future initiatives. The fourth chamber can be utilized for equipment and various research testing scenarios. ETC’s suite of chambers will support activities for the U.S. Government’s aeromedical research mission, which include:Human performance assessment in moderate...

Continue reading

Golden Birch Announces Status of Keveri Option Party

TIMMINS, Ontario, Sept. 16, 2020 (GLOBE NEWSWIRE) — Golden Birch Resources Inc. (GBRX:CSE) (“Golden Birch” or the “Company”) wishes to advise the market that it has been informed of the commencement of court proceedings in the Western Australia Supreme Court by a shareholder of Papuan Minerals Pty Ltd (“PMPL”) against other shareholders of PMPL based on alleged “oppression”.Golden Birch is a party to an option agreement dated March 20, 2020 (the “Option Agreement”) among PMPL and Papuan Minerals Ltd (“PML”), a wholly-owned subsidiary of PMPL and the holder of the exploration licences that make up the Keveri project (“Keveri Project”). Pursuant to the Option Agreement, Golden Birch holds the option to earn up to an 85% interest in PML.The Company does not expect these legal proceedings will have a material impact on the Company....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.